The price of this share is at 14,12$, UroGen Pharma Ltd, with address at 400 ALEXANDER PARK, PRINCETON, New Jersey, 8540, United States, is a publicly traded company and its visible heads at the moment are Elizabeth Barrett (President, Chief Executive Officer & Director), Marina Konorty (EVP-Research & Development & Technical Operations), Mark P. Schoenberg (Chief Medical Officer), Molly Henderson (Chief Financial & Accounting Officer), Moran Mieron (Director-Research & Pre-Clinical Affairs), Polly A. Murphy (Chief Business Officer). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 14,01$ moving between 13,69$ and 14,32$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The opening price that appears as last recorded is desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
